Invitrx Therapeutics

Irvine, United States Founded: 2003 • Age: 23 yrs
Develops cell therapy products for wound healing, aesthetics, and regenerative medicine.

About Invitrx Therapeutics

Invitrx Therapeutics is a Healthcare company based in Irvine (United States) founded in 2003 by Habib Torfi. It develops cell therapy products for wound healing, aesthetics, and regenerative medicine. It operates on a B2B and D2C model. Its chief executive, as recorded, is Habib Torfi. Invitrx Therapeutics offers products and services including Reluma, Skin Grafts, and Cord Blood Stem Cell Products. Its focus areas include Life Sciences, Biotechnology, Stem Cell Products and Medical Applications. Its legal entity is Invitrx Therapeutics, Inc. Similar companies include Avidity Biosciences, Vividion Therapeutics and Korro Bio; 3 of its 3 listed similar companies have raised funding.

Company details

Invitrx Therapeutics, Inc. specializes in creating cell therapy products like skin grafts and stem cell solutions for applications in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Based in Irvine, California, the company manufactures these products in a state-of-the-art lab and focuses on research and development. They supply physicians and researchers with innovative solutions, emphasizing quality and safety in regenerative medicine.

  • Headquarters Irvine, United States
  • Founders Habib Torfi
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website invitrx.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Invitrx Therapeutics, Inc.
Operational Areas

Products & Services of Invitrx Therapeutics

Invitrx Therapeutics offers a comprehensive portfolio of products and services, including Reluma, Skin Grafts, and Cord Blood Stem Cell Products.

Reluma
Cell Therapy Product

Product for regenerative medicine in aesthetics and wound healing.

Skin Grafts
Medical Device

Solutions for burn patients and reconstructive procedures.

Cord Blood Stem Cell Products
Research Tool

Products for stem cell research and clinical applications.

People of Invitrx Therapeutics

17 people are tracked at Invitrx Therapeutics (3 in leadership, 14 in board & advisors).

NameRoleGroup
Habib Torfi
Founder, CEOLeadership
Marco Zahedi
Chief Medical OfficerLeadership
Ranjan Gupta
Chief Scientific OfficerLeadership
Chen Wei-Cheng
Scientific AdvisorBoard & advisors
Wu Chung-Ken
Medical AdvisorBoard & advisors
Lawton W. Tang
Medical AdvisorBoard & advisors
Jonathan R. Pirnazar
Medical AdvisorBoard & advisors
Herbert Lamblet
Medical AdvisorBoard & advisors
Shyh-Mine Lii
Medical AdvisorBoard & advisors
Zain Kadri
Medical AdvisorBoard & advisors
Xerxez Calilung
Medical AdvisorBoard & advisors
Michael A. Meshkin
Medical AdvisorBoard & advisors
Gregory R.D. Evans
Medical AdvisorBoard & advisors
Jane A. Cases
Medical AdvisorBoard & advisors
Hassan Badday
Medical AdvisorBoard & advisors
Amel Touhmi
Medical AdvisorBoard & advisors
Lin Yu-Ming
Scientific AdvisorBoard & advisors
Premium access

Complete people profiles for Invitrx Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Similar companies to Invitrx Therapeutics

Invitrx Therapeutics has 3 listed similar companies in our database, 3 of them funded. They include Avidity Biosciences, Vividion Therapeutics and Korro Bio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
vividion.com2016Oceanside, United States$270.5M123
Developing novel drugs based on a proteome-wide ligand and target discovery platform
korrobio.com2018Cambridge, United States$4M77
RNA-editing technologies are provided for precision medicine applications.
Premium access

Detailed similar companies of Invitrx Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Invitrx Therapeutics

Websites that share an audience with Invitrx Therapeutics (invitrx.com).

Similar websites

Websites whose visitors overlap most with Invitrx Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
amberstonebio.com
97%
View details
nkgenbiotech.com
88%
2.3K#7,342,022View details

Top companies in Cell Therapy

3 companies that operate in the same segment as Invitrx Therapeutics (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Invitrx Therapeutics

Invitrx Therapeutics was founded in 2003.

Invitrx Therapeutics is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Habib Torfi is the CEO of Invitrx Therapeutics, as recorded in our data. They have also founded this company.

Invitrx Therapeutics, Inc. specializes in creating cell therapy products like skin grafts and stem cell solutions for applications in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Based in Irvine, California, the company manufactures these products in a state-of-the-art lab and focuses on research and development. They supply physicians and researchers with innovative solutions, emphasizing quality and safety in regenerative medicine.

Invitrx Therapeutics's top competitors include Avidity Biosciences, Vividion Therapeutics and Korro Bio.

Invitrx Therapeutics offers Reluma, Skin Grafts, and Cord Blood Stem Cell Products.

Invitrx Therapeutics operates through Invitrx Therapeutics, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available